Emergence of the COVID 19 Epidemic in the City of Nice
Sponsor
Centre Hospitalier Universitaire de Nice (Other)
Overall Status
Completed
CT.gov ID
NCT04449094
Collaborator
(none)
200
1
1.2
169.1
Study Details
Study Description
Brief Summary
Descriptive analysis of the appearance of the first cases of COVID 19 diagnosed in the city of Nice. Analysis of the association of socio-demographic factors with the viremia attack rate according to the district of residence.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
200 participants
Observational Model:
Ecologic or Community
Time Perspective:
Retrospective
Official Title:
Socio-demographic Factors and Emergence of the COVID 19 Epidemic in the City of Nice in 2020
Actual Study Start Date
:
Feb 28, 2020
Actual Primary Completion Date
:
Mar 30, 2020
Actual Study Completion Date
:
Apr 4, 2020
Outcome Measures
Primary Outcome Measures
- Attack rate [1 month]
Diagnosed cases of COVID 19 divided by the population by district and multiplied by 100,000
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- People resident in city of Nice at the COVID diagnosis
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHU de Nice | Nice | France | 06200 |
Sponsors and Collaborators
- Centre Hospitalier Universitaire de Nice
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier:
NCT04449094
Other Study ID Numbers:
- 20dspcovid01
First Posted:
Jun 26, 2020
Last Update Posted:
Jun 26, 2020
Last Verified:
Jun 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No